Anzeige
++++++ NurExone Biologic: Bahnbrechend wie BioNTech – jetzt die Rallye?! ++++++
Appili Austausch ISIN: CA03783R1073 Forum: Aktien User: Nasemütze
0,04 CAD
+14,29 %+0,01
17. Jun, 18:32:20 Uhr,
Toronto
Kommentare 159
BadensBester,
25.09.2023 15:51 Uhr
0
https://finance.yahoo.com/news/appili-therapeutics-announces-u-fda-115400400.html
BadensBester,
27.09.2023 22:01 Uhr
0
https://www.stocktitan.net/news/APLIF/appili-therapeutics-presents-at-the-10th-international-tularemia-cea6wkf3qa53.html
PfeilundBogen,
06.10.2023 17:07 Uhr
0
was für eine Gurke, fällt wieder ... Börse ist nur noch zum Abgewöhnen
PfeilundBogen,
20.07.2023 22:14 Uhr
0
https://finance.yahoo.com/news/aplif-executes-initial-contract-usafa-131500486.html
PfeilundBogen,
08.05.2023 16:02 Uhr
1
Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that the Company has executed the initial contract with the U.S. Air Force Academy (USAFA) for the previously announced funding of the ATI-1701 program. This contract represents the first stage of funding from the previously announced award from the U.S. Department of Defense (“DOD”). This initial funding, in the amount of US$7.3 million, will be used to kick-off ATI-1701 early-stage development and regulatory activities. As the initial activities progress, Appili will be engaging USAFA for additional tranches of funding to continue development through IND. ATI-1701, our biodefense vaccine candidate, is the Company’s potential first-in-class vaccine candidate for the prevention of infection with Francisella tularensis, the causative agent of tularemia and a top-priority biothreat.
PfeilundBogen,
08.05.2023 16:01 Uhr
0
https://ceo.ca/@businesswire/appili-therapeutics-secures-contract-for-ati-1701-funding
PfeilundBogen,
18.04.2023 16:19 Uhr
0
Appili Therapeutics Inc. (TSX: APLI; OTCQB: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced that Dr. Don Cilla, Appili President and Chief Executive Officer, will present at the Bloom Burton & Co. Healthcare Investor Conference taking place on April 25 and 26, 2023.
The presentation will include an update on Appili’s pipeline of novel anti-infectives; ATI-1701, a vaccine for tularemia being funded by the U.S. Government through IND submission and ATI-1801, a treatment for cutaneous leishmaniasis, a disfiguring infection of the skin. Appili believes that both programs may be eligible to receive FDA Priority Review Vouchers upon approval.
BadensBester,
05.04.2023 1:55 Uhr
0
https://financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/appili-therapeutics-appoints-dr-gary-nabors-as-chief-development-officer
PfeilundBogen,
08.02.2023 19:44 Uhr
0
https://ceo.ca/@businesswire/appili-therapeutics-announces-that-fda-accepts-the
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -5,06 % | |
2 | Gme sinnvoller austausch der apes | -5,06 % | |
3 | NVIDIA Hauptdiskussion | +0,94 % | |
4 | SUPER MICRO Hauptdiskussion | +1,59 % | |
5 | gme heute gehts ab | -5,06 % | |
6 | PAYPAL Hauptdiskussion | -0,90 % | |
7 | APPLE Hauptdiskussion | -0,62 % | |
8 | EVOTEC Hauptdiskussion | -1,38 % | |
9 | AIXTRON Hauptdiskussion | -0,78 % | |
10 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,78 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | GAMESTOP Hauptdiskussion | -5,06 % | |
2 | Gme sinnvoller austausch der apes | -5,06 % | |
3 | NVIDIA Hauptdiskussion | +0,94 % | |
4 | SUPER MICRO Hauptdiskussion | +1,59 % | |
5 | gme heute gehts ab | -5,06 % | |
6 | PAYPAL Hauptdiskussion | -0,90 % | |
7 | APPLE Hauptdiskussion | -0,62 % | |
8 | EVOTEC Hauptdiskussion | -1,38 % | |
9 | AIXTRON Hauptdiskussion | -0,78 % | |
10 | CYTOMX THERAPEUTICS INC. Hauptdiskussion | -0,78 % | Alle Diskussionen |